Read previewSix months after he started taking a weight-loss drug, a 62-year-old man was hospitalized with heart palpitations, tremors, confusion, fever, and sweating.
The man, from Colorado, had been prescribed the drug tirzepatide (the active ingredient in Mounjaro and Zepbound) to lose weight.
Over time, the patient decreased his insulin dose as he lost weight, but didn't change his thyroid medication.
This highlights the potential risks of losing weight too quickly, and the need for medical supervision while using the drugs, they said.
AdvertisementOzempic and Wegovy, brand names for semaglutide showed weight loss of about 15% over a similar time period.
Persons:
—, Barbara Davis, they've
Organizations:
Service, Business, Barbara, Barbara Davis Center, Diabetes, University of Colorado, FDA
Locations:
Colorado